ACTING CHIEF EXECUTIVE OFFICER AND CHIEF SCIENTIFIC OFFICER, STADIUS BIOPHARMA LLC
New Orleans, Louisiana, United States
Dr. Wilson is the Acting CEO and CSO of Stadius Biopharma and founder of Autoimmune Technologies. He is a founder of Stadius Biopharma LLC. Previously he was a research biologist at Carnegie Mellon University, an assistant professor of pathology and laboratory medicine at Tulane University Medical School, and served on study sections of the Center for Scientific Review of the National Institutes of Health (NIH). Dr. Wilson led the team that developed the highly sensitive detection reagent used in the first emergency use authorized (EUA) rapid test for Ebola virus infection, a test which is also used in the recently 510(k)-approved rapid antigen test for the detection of Ebola among other accomplishments. He holds degrees in biology from Baylor University and the University of Texas at Dallas and a Ph.D. in molecular and cell biology from the University of Texas at Dallas. Please see www.stadiusbio.com for additional information.